Anna Berghuis

Portrait Anna Berghuis
We are the bridge between new fundamental biomedical knowledge and the hospital and clinic.
Name
Anna Berghuis
Programme
Human Biology
Study start date
Current role
Student Human Biology
Previous education
Bachelor's Health Science at Maastricht University

Anna Berghuis is a Master's student Human Biology at Radboud University. In the first year of the programme Anna wrote a testimonial about the Master's and atmosphere in Nijmegen. 

What do you like about the Master's specialisation and why?

I love the focus on translational research. With your research, you can make changes and improvements in existing disease therapies or find a whole new biomarker or therapy. Furthermore, I enjoy the cooperation with (specialised) physicians, chemists, and analysts during the internship.

What do you think about the atmosphere in class?

Many classes are interactive, leading to interesting discussions between the lecturers and the students and a good atmosphere.

What do you find most challenging in your Master’s specialisation?

The first months of mandatory courses were very busy and a bit overwhelming for me. But you notice afterwards how much you have learned and how useful these courses are for your internship. Finding a good internship was also a challenge because you were one of many that were looking at the same places for an interesting internship.

Are you currently doing an internship? Or what is your thesis about?

I just started my first internship in the gynaecology department of Radboudumc about endometrial cancer. The aim of our study is to analyze a potential new biomarker for endometrial cancer, which could be used for diagnosing EC and help to determine the prognosis.

Why do you think is it important that there are people out there with this degree? 

I think it is very important that there are people out there with this Master's degree because we are the bridge between new fundamental biomedical knowledge and the hospital and clinic. If there is no translational research, we miss the chance of improving or discovering drugs or therapies.